TruBios Partner Elected to National Academy of Sciences
Vanderlei Salvador Bagnato was elected a member of the National Academy of Sciences of the United States. Bagnato invented the Cerca device with Roberto Trujillo, chief executive of TruBios, a biotech company located on the Johns Hopkins Montgomery County Campus. The device, which is on its way to being approved for use in Brazil, uses photodynamic therapy to diagnose and treat cervical cancer.
Trujillo said Bagnato was the molecular physicist genius behind the device.
“It’s great for us to be recognized with that kind of status,” Trujillo said. “There’s more trust for the product. There’s more trust for the investment.”
The National Academy of Sciences is a private society of scholars dating back to 1863. The academy’s goal, according to its website, is to provide “independent, objective advice to the nation on matters related to science and technology.”
Scientists are elected to the academy by their peers.
Bagnato, who lives in Brazil, pursued pioneering work in the fields of atomic and molecular physics. He has focused on quantum turbulence, laser cooling and trapping of neutral atoms, as well as the application of optics and lasers in dentistry and medicine.
He said he has published more than 350 papers in international journals with more than 3,000 citations. During his academic life, he has supervised more than 60 graduate students, and is presently supervising graduate and undergraduate students involved in research programs at the University of Sao Paulo, where he teaches.
“Transforming science into benefits for our society is what gives relevance to our work,” Bagnato said. “In this sense, the collaboration with Dr. Roberto Trujillo from TruBios is one great opportunity for that. We are developing, together, new ways to treat the cervical cancer. That is certainly a great work and I do hope we can be successful.”
CATEGORY: Tenant News